Pancreatic Cancer Research

ResearcherAuburn UniversityActive in the last 2 years

Gary Anthony Piazza

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-4418-887X; OpenAlex author ID A5071802884; NIH RePORTER profile ID 2403841. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
1
Labs led
1
Collaborators
25
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper, 1 grant

Papers 4

  1. ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma Co-author DOI 10.64898/2026.02.11.705411↗
  2. ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12943-025-02288-9↗
  3. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer. Co-author DOI 10.1186/s13046-019-1308-7↗
  4. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and… Co-author DOI 10.1074/jbc.m113.484576↗

Grants 1

  1. Advancing Pan-RAS Inhibitors for Colorectal Cancer Interception: A Dual Approach Integrating Natural Product Drug Discovery and Preclinical Development R01CA316420↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yulia Y. Maxuitenko · 3 shared papers, 1 shared grant, 2019–2026 · strength 1.35
  2. Adam B. Keeton · 3 shared papers, 1 shared grant, 2019–2026 · strength 1.35
  3. Angela Isabel Calderon · 1 shared grant, 2026 · strength 0.86
  4. Donald J Buchsbaum · 2 shared papers, 2025–2026 · strength 0.41
  5. Sujith Sarvesh · 2 shared papers, 2025–2026 · strength 0.41
  6. Dhana Sekhar Reddy Bandi · 2 shared papers, 2025–2026 · strength 0.41
  7. Ganji Purnachandra Nagaraju · 2 shared papers, 2025–2026 · strength 0.41
  8. Jeremy B. Foote · 2 shared papers, 2025–2026 · strength 0.41
  9. Mehmet Akce · 2 shared papers, 2025–2026 · strength 0.41
  10. Asfar Sohail Azmi · 2 shared papers, 2025–2026 · strength 0.41
  11. Bassel F. El‐Rayes · 2 shared papers, 2025–2026 · strength 0.41
  12. Upender Manne · 1 shared paper, 2025 · strength 0.19
  13. Julienne L. Carstens · 1 shared paper, 2025 · strength 0.19
  14. Karina Jin Yoon · 1 shared paper, 2025 · strength 0.19
  15. Alice Domenichini · 1 shared paper, 2019 · strength 0.08
  16. Aleksandra Adamska · 1 shared paper, 2019 · strength 0.08
  17. Vincenzo De Laurenzi · 1 shared paper, 2019 · strength 0.08
  18. Pierluigi Di Sebastiano · 1 shared paper, 2019 · strength 0.08
  19. Verena Damiani · 1 shared paper, 2019 · strength 0.08
  20. Marco Falasca · 1 shared paper, 2019 · strength 0.08
  21. Seema Singh · 1 shared paper, 2013 · strength 0.03
  22. Arun Bhardwaj · 1 shared paper, 2013 · strength 0.03
  23. Sumit Arora · 1 shared paper, 2013 · strength 0.03
  24. Sanjeev K. Srivastava · 1 shared paper, 2013 · strength 0.03
  25. Ajay P. Singh · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.